The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Lifespot Health (LSH) has appointed Matthew Golden as CEO effective immediately
  • Matthew is a commercial healthcare professional with almost 20 years experience in the pharmaceutical industry both in Australia and overseas
  • He has worked with the likes of Medical Developments International where he drove the sales of the ‘Green Whistle’ used in pain relief
  • At Lifespot, Matthew will review the company’s telehealth and medical cannabis inhaler strategies, and define the timing of its Medihale clinical trial
  • Additionally, Rodney Harrington and Frank Cannavo will resume their respective roles of Non-Executive Chairman and Non-Executive Director
  • Lifespot is up 17.7 per cent on the back of this news with shares trading for six cents each

Lifespot Health (LSH) has appointed Matthew Golden as CEO effective immediately.

Matthew is a commercial healthcare professional with almost 20 years experience in the pharmaceutical industry both in Australia and overseas.

He has a Masters of Marketing and a Bachelor of Science, both from Monash University in Melbourne.

He primarily worked at Pfizer Pharmaceuticals and Medical Developments International where he drove the sales of pain management products such as Penthrox which is known as the ‘Green Whistle’ for pain relief.

At Lifespot, Matthew will review the company’s telehealth and medical cannabis inhaler strategies, and define the timing of its Medihale clinical trial.

Additionally, Rodney Harrington and Frank Cannavo will resume their respective roles of Non-Executive Chairman and Non-Executive Director.

Lifespot is up 17.7 per cent on the back of this news with shares trading for six cents each at 3:24 pm AEDT.

LSH by the numbers
More From The Market Online

Recce breathes better on positive lung infection drug pilot test results

Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327,…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Botanix isn’t sweating on FDA approval for Sofdra

Botanix has submitted the last label materials to the FDA seeking approval for Sofdra™ a prescription…

Singular Health launches upgraded DICOM viewer, with patient-friendly features for engagement with medical records

Singular Health Ltd has launched an upgraded version of its DICOM viewer, set to allow greater…